eli lilly glp-1 supply news today Lilly's Popular Weight Loss Drug, Zepbound, Is Getting a Price Cut Lilly is selling $12.9 billion

Targeting human oligodendrocyte progenitors for myelin repair

This is the proven science behind GLP-1 medications, also known as GLP-1 receptor agonists medicines built around glucagon-like peptide-1, a natural gut hormone, now more accessible in India in 2026

The drug is about to be tested on 30 people who will be treated with Johnson & Johnsons blood cancer medication teclistamab (sold as Tecvayli), at six hospitals in Britain, in a trial led by the University of Manchester and the Christie NHS Foundation Trust

Intestinal barrier disruption as a cause of mortality in combined radiation and burn injury

Okolo S

If the carnitine shuttle is compromised, the heart and blood vessels cannot access the fatty acids they desperately need for fuel